Of particular note, in lung adenocarcinoma cells, candesartan enhanced their susceptibility to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis [54]. Here, TNFSF10 is linked to lung adenocarcinoma.